Stock data
Achieve Life Sciences, Inc. (ACHV)
Achieve Life Sciences, Inc. (ACHV) reported net income of -US$54.65M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | — | -US$54.65M | — |
| 2024 | — | — | — | -US$39.83M | — |
| 2023 | — | — | — | -US$29.82M | — |
| 2022 | — | — | — | -US$42.35M | — |
| 2021 | — | — | — | -US$33.15M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$74.77M | — |
| 2026-03-31 | — | -US$10.17M | — |
| 2025-12-31 | — | -US$14.66M | — |
| 2025-09-30 | — | -US$14.44M | — |
| 2025-06-30 | — | -US$12.72M | — |
| 2025-03-31 | — | -US$12.83M | — |
| 2024-12-31 | — | -US$12.36M | — |
| 2024-09-30 | — | -US$12.51M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.